title: Optimal thresholds of the lecithin/sphingomyelin ratio and lamellar body count for the prediction of the presence of phosphatidyl glycerol in diabetic women.
abstract: OBJECTIVE
  To assess the optimal thresholds of the lecithin/sphingomyelin (L/S) ratio and lamellar body count for the prediction of the presence of phosphatidyl glycerol (PG) in diabetic pregnant women.
  
  
  METHODS
  We accessed a database of clear amniotic fluid specimens obtained by transabdominal amniocentesis in diabetic women with singleton non-malformed fetuses. PG results were classified as 'absent' or 'present'. Receiver operating characteristic (ROC) curve analysis was constructed of different L/S ratios and lamellar body counts to identify the optimal threshold for prediction of the presence of PG. Sensitivity was defined as the rate of L/S ratio and lamellar body count above specific thresholds among cases with present PG. The false-positive rate was that of L/S ratios or lamellar body counts above specific thresholds among cases with absent PG. Statistical analysis included one-way analysis of variance with post-hoc analysis, with p < 0.05 considered significant.
  
  
  RESULTS
  A total of 76 consecutive women were included in the analysis, 74% (n = 56) using insulin and the remainder treated by diet alone. L/S and PG results were both available in 72 women. PG was reported as 'present' in 70% (51/73) of specimens. As expected, there was a significant relationship between L/S ratios and presence of PG (area under the curve = 0.932, p < 0.001). An L/S ratio of > or = 3.0 represented the optimal trade-off between sensitivity (68%) and false-positive rate (6%) in the prediction of present PG. Similarly, there was a significant relationship between lamellar body count values and presence of PG (area under the curve = 0.976, p < 0.001). A lamellar body count of > or = 50 000 represented the optimal trade-off between sensitivity (92%) and false-positive rate (0%) in the prediction of present PG.
  
  
  CONCLUSIONS
  In diabetic pregnant patients, the presence of PG in the amniotic fluid more closely corresponded to an L/S ratio of > or = 3.0 or to a lamellar body count of > or = 50,000.
authors.affiliation: Perinatal Diagnostic Center, Inova Alexandria Hospital, Virginia 22304, USA.
authors.forename: A
authors.initials: A
authors.lastname: Ghidini
authors.forename: C Y
authors.initials: CY
authors.lastname: Spong
authors.forename: K
authors.initials: K
authors.lastname: Goodwin
authors.forename: J C
authors.initials: JC
authors.lastname: Pezzullo
mesh_terms: D000328:Adult; D000649:Amniocentesis / Q000592:standards; D000653:Amniotic Fluid / Q000378:metabolism; D003920:Diabetes Mellitus; D005189:False Positive Reactions; D005260:Female; D005325:Fetal Organ Maturity; D006801:Humans; D002479:Inclusion Bodies / Q000378:metabolism; D007231:Infant, Newborn; D008168:Lung / Q000196:embryology*; D010713:Phosphatidylcholines / Q000378:metabolism*; D010715:Phosphatidylglycerols / Q000378:metabolism*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000378:metabolism*; D011296:Prenatal Diagnosis / Q000592:standards*; D012372:ROC Curve; D012680:Sensitivity and Specificity; D013109:Sphingomyelins / Q000378:metabolism*
chemical_list: D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; D013109:Sphingomyelins